PINK:SKYE

Skye Bioscience Stock Predictions

etoro logo Buy SKYE
*Your capital is at risk
$0.770
+0.0563 (+7.89%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SKYE Prediction Chart

SKYE Predictions History

Latest community submissions for SKYE.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 19, 2021 Bullish Awaiting close 1
James Duran James Duran @JamesDuran.203187
Apr 19, 2021 Bullish Awaiting close 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SKYE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SKYE BIOSCIENCE, INC.
Skye Bioscience
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE